Is this the best semax source available anywhere?

It is the best we can evidence from published documents, which is a narrower claim than it sounds. We have not tested competitors in a laboratory and will not imply otherwise. If you find a certificate covering a shipping lot with compendial sterility testing and a second lab, that beats this one on our own scheme.

Why does endotoxin carry almost a third of the score?

Because it is the half of FDA's stated concern that purity testing cannot reach, and because the market almost universally omits it. Weighting a criterion by how commonly it is satisfied would produce a ranking that rewards whatever is easy.

Does 99.886% purity not settle the question on its own?

No. Purity is the proportion of powder that is the intended sequence. A powder can be extremely pure and still carry a pyrogen load, because endotoxins are bacterial cell wall fragments invisible to an HPLC trace.

Should a second laboratory matter if one already ran the tests?

Generally yes, since a second independent document raises confidence in a result. What it cannot do is add a test neither laboratory ran, which is why testing scope outranks laboratory count above.

Does a high score mean the compound is safe?

No, and this is the most important line on the page. The score measures how well one batch is documented. FDA's position is that it lacks sufficient information to know whether Semax would cause harm in humans, and no laboratory report addresses that.

What is the one question worth asking any seller?

Whether they will send the certificate covering the exact lot they intend to ship, including any endotoxin result. It tests batch traceability and testing scope in a single sentence, and the manner of the reply is as informative as its content.

Best Semax Source: How the Ranking Was Built

Summary: The criteria are derived from the only concern FDA has put on record about this compound, published as points before any vendor is scored, so you can argue with the method rather than the conclusion.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

Best semax source is a question nobody should answer without publishing the method first, because a ranking with a hidden weighting is an opinion with a table drawn around it. So here is the 100-point scheme, where each criterion comes from, and only then the score.

The source being scored is the one we link, which is below, so you can hold it against the method as you read.

Where readers actually buy it

Ascension Peptides — Semax

Research-grade Semax, tested by two outside labs and shipped from the US. The code below takes half off the vial.

Code at checkoutPEPTIDEDECK50% off

Semax · 10 mg$59.99$30.00$3.00/mgGet the 10 mg →

The published certificate for batch 30-05260628 carries a kinetic chromogenic LAL endotoxin test to USP Chapter 85, reporting under 0.20 EU/mL against a 0.5 EU/mL limit, plus a sterility screen. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price.

Batch certificates from two independent labs
Free shipping over $250
Ships same day if ordered before 2pm CST

Sold for laboratory research only and not for human consumption. These are affiliate links: we may earn a commission at no cost to you, and it does not change what we recommend. Prices checked August 21, 2026.

What can be ranked, and what cannot

We link Ascension Peptides and earn a commission on purchases made through that card. It is disclosed there and in our disclaimer. Publishing the scoring scheme before the result is the only thing that makes such a disclosure worth reading, so the scheme goes first and the score is whatever the scheme produces.

Two limits, stated plainly. We have not laboratory-tested anything, so every point below is awarded on published documents you can open yourself, which means the ranking measures documentation rather than product quality. And no score here says anything about whether Semax should be used by anyone. FDA's recorded position is that it lacks the information to know whether the compound would cause harm in humans ^[1], and a certificate does not touch that question.

Semax is also not a GLP-1, in case you arrived through this site's incretin coverage. It is a synthetic heptapeptide, Met-Glu-His-Phe-Pro-Gly-Pro, the ACTH(4-7) fragment with a Pro-Gly-Pro tail added to slow enzymatic breakdown, PubChem CID 9811102, formula C37H51N9O10S, molecular weight 813.9 ^[5]. Registered in Russia, approved in the West for nothing, with an evidence base nothing like the trials behind semaglutide or tirzepatide.

Best semax source: where the criteria come from

The criteria are not ours. They are derived from the single substantive statement any regulator has made about this compound. FDA writes that compounded drugs containing semax "may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities", and that it "lacks sufficient information to know whether the drug would cause harm if administered to humans" ^[1].

Read that as a specification rather than a warning and it decomposes into three testable questions. Is this the molecule it claims to be? What else is in the powder alongside it? And what biological load is it carrying that a chemical assay cannot see? The first is identity, the second is purity and elemental impurities, the third is endotoxin and sterility. Everything else is commerce.

Criterion	Points	The question it answers
Pyrogen and microbial load: endotoxin plus a sterility or bioburden result	30	The half of FDA's concern that no purity assay can reach, and the criterion most of this market simply omits
Lot traceability and independent verification	20	Does the document describe the vial you will receive, from a named laboratory, in a way you can check without the seller
Purity against a stated specification	15	How much of the powder is the intended sequence, measured against a threshold printed beside the result
Identity by mass spectrometry	15	Whether it is this heptapeptide at all, rather than a cheaper or truncated sequence under the right name
Elemental impurities	5	Catalyst and process metals left behind by synthesis, with per-element limits
Provenance and logistics	8	Domestic stock, a stated dispatch cutoff, a published refund path, a return that is physically possible
Honest legal framing	5	Research-use labelling and no human-use or clinical claims anywhere on the listing
Price	2	It matters least. A cheap vial of the wrong material is worth nothing at any price

Pyrogen and microbial load takes almost a third of the total for one reason: it is the criterion the market fails. Purity certificates are everywhere. Endotoxin results are close to absent, and endotoxins are bacterial cell wall fragments that survive processes which kill the organisms that produced them, so nothing in an HPLC trace will ever reveal them. A criterion should reflect what can go wrong, not what is convenient to score.

Price sits at 2 deliberately. The spread between credible domestic sellers is a few dollars. The spread between a documented batch and an undocumented one is the entire value of the purchase.

The scoring, criterion by criterion

Pyrogen and microbial load, 30 points. Awarded 25. The certificate for batch 30-05260628, report KVR-2026-E848E0 from Kovera Labs, carries a quantitative bacterial endotoxin test by kinetic LAL to USP Chapter 85: result below 0.20 EU/mL against an acceptance limit of 0.5 EU/mL, E. coli O111:B4 standard, detection range 0.01 to 1.0 EU/mL, positive and negative controls behaving as expected, final determination pass ^[3]. There is also a rapid sterility screen returning no bacterial growth and no fungi or yeast over two days of incubation at 30 to 35 degrees Celsius. Full marks on the endotoxin half. Five points come off because the sterility result is a rapid screen rather than a compendial test, a limitation the report states about itself, noting that full USP Chapter 71 testing may be required for regulatory compliance ^[3].

Lot traceability and independent verification, 20 points. Awarded 16. The document is tied to a specific batch, issued by a named laboratory, signed by a lab director, with a report number and a separate access code on each analytical page against a verification address at koveralabs.com/verify, which resolves. Four points come off for two reasons: we have not confirmed that submitting a code returns the document, and one published certificate does not demonstrate that every lot receives one of this scope.

Purity against a stated specification, 15 points. Awarded 15. Purity 99.886% by RP-HPLC on a C18 column with diode array detection at 214 nm, against a reference standard of greater than 98% printed beside the result ^[3]. The printed specification is what earns the points. A bare percentage with no threshold is a decoration rather than a test.

Identity by mass spectrometry, 15 points. Awarded 15. Identity confirmed as Semax by LC-MS, with the sample block carrying formula C37H51N9O10S and CAS number 80714-61-0, both matching the public record ^[5].

Elemental impurities, 5 points. Awarded 5. ICP-MS with EPA-referenced methods: lead below 0.5 ppm against a 10 ppm limit, arsenic below 0.15 against 1.5, cadmium below 0.05 against 0.5, mercury below 0.3 against 3, with spike recoveries of 91% to 102% against a 70% to 150% criterion, which is the evidence the method worked in this matrix ^[3].

Provenance and logistics, 8 points. Awarded 8. Domestic stock, same-day dispatch stated for orders before 2pm CST, free shipping from $250, published quantity tiers.

Honest legal framing, 5 points. Awarded 2. The listing carries a research-use-only statement and no dosing guidance, which is correct. It also describes neuroprotective and cognitive-enhancing properties in research models, which is claim-adjacent language on a compound with no approved indication anywhere. Three points off.

Price, 2 points. Awarded 2. $59.99 list, $30.00 with the code PEPTIDEDECK, which is $3.00 per milligram on the label weight. Competitive without being implausible.

Total: 88 out of 100.

What that 88 does and does not mean

It means the published documentation for this batch answers more of the questions FDA implicitly asked than anything else we can point at in this market. It does not mean 88 out of 100 on whether anyone should use the compound, and that second number is not available to us or to anybody else. No adequate human data exists, which is the whole content of FDA's position ^[1].

It is also a score about one batch. Every figure above describes lot 30-05260628. If the vial that arrives carries a different lot, the score you just read was about someone else's powder, and the correct response is to ask for the matching document rather than to assume continuity.

What would move it, and what we did not score

Four things would push it higher: a compendial sterility test rather than a rapid screen, a second independent laboratory covering the same lot, a demonstrated pattern of publishing documents of this scope for every batch, and listing copy stripped of properties language. Three of those are within the vendor's control this quarter.

Things we deliberately left unscored, because they are noise dressed as evidence: review counts, trust badges, brand age, forum reputation, packaging quality, and any price difference below about ten dollars a vial. None of them predict whether the powder is the molecule.

We also left out a regulatory row, because there are no gradations available. Semax appears on no current FDA 503A bulks category list, in none of categories 1, 2 or 3 as updated May 14, 2026 ^[2]. It appears instead on FDA's separate listing of substances nominated but withdrawn, which the agency describes as substances previously in category 2 of the interim policies that were withdrawn by the nominators ^[1]. So it was nominated, was placed in category 2 during evaluation, and the nomination was pulled. It is on no list today, and current category 2 holds exactly six substances, none of them this one ^[1]. No seller can score better or worse on any of that, because it is a fact about the compound.

The same method, one batch across

The most convincing evidence that a scoring scheme is doing real work is what happens when you apply it somewhere it produces an uncomfortable answer.

The same vendor's February 2026 round produced thinner documents on both compounds. The Semax certificate for lot 30-01260229 and the Selank one for lot 29-01260229 ^[4], both from MZ Biolabs, report purity and identity with the chromatogram and peak list printed, and a measured fill weight in each vial. Good identity work, real lot traceability, an unusual and creditable disclosure of assayed mass. And no endotoxin test, no LAL result, no sterility screen and no metals panel anywhere on either document.

Run the scheme above on either February document and the entire 30-point block goes, along with the 5 for elemental impurities. Same storefront, same compounds, different testing round, and our full working on the neighbouring product is in the Selank ranking and the row it fails.

The comparison matters more than either score. Which testing you get is a batch question rather than a product question: the scope widened across this catalogue in June 2026, not for one compound. So read every certificate on the product page rather than only the one that is a clickable link, and treat "is there an endotoxin result for the lot you are shipping me" as a fair question with a realistic chance of a real answer, from any seller.

The weighting itself moves by compound, because the binding constraint moves. On NAD+ the deciding factor is manufacturing grade, which is why that ranking leads on testing scope and settles ties on price. Here it is pyrogen load, because that is what the regulator named.

Questions about picking a source

Is this the best semax source available anywhere?: It is the best we can evidence from published documents, which is a narrower claim than it sounds. We have not tested competitors in a laboratory and will not imply otherwise. If you find a certificate covering a shipping lot with compendial sterility testing and a second lab, that beats this one on our own scheme.
Why does endotoxin carry almost a third of the score?: Because it is the half of FDA's stated concern that purity testing cannot reach, and because the market almost universally omits it. Weighting a criterion by how commonly it is satisfied would produce a ranking that rewards whatever is easy.
Does 99.886% purity not settle the question on its own?: No. Purity is the proportion of powder that is the intended sequence. A powder can be extremely pure and still carry a pyrogen load, because endotoxins are bacterial cell wall fragments invisible to an HPLC trace.
Should a second laboratory matter if one already ran the tests?: Generally yes, since a second independent document raises confidence in a result. What it cannot do is add a test neither laboratory ran, which is why testing scope outranks laboratory count above.
Does a high score mean the compound is safe?: No, and this is the most important line on the page. The score measures how well one batch is documented. FDA's position is that it lacks sufficient information to know whether Semax would cause harm in humans, and no laboratory report addresses that.
What is the one question worth asking any seller?: Whether they will send the certificate covering the exact lot they intend to ship, including any endotoxin result. It tests batch traceability and testing scope in a single sentence, and the manner of the reply is as informative as its content.

Best semax source, on a method published before the result, comes out at 88 out of 100 for documentation, with 12 points lost to a rapid sterility screen, an unconfirmed verification route and some properties language on the listing. Those are checkable deductions rather than a rounded verdict, and if the vendor fixes them the number moves. What no number here moves is the compound's standing, which remains where FDA left it: nominated, withdrawn, unapproved and unevaluated.